160 related articles for article (PubMed ID: 8800434)
1. Laboratory examinations correlated with severity of dementia.
Oishi M; Mochizuki Y; Yoshihashi H; Takasu T; Nakano E
Ann Clin Lab Sci; 1996; 26(4):340-5. PubMed ID: 8800434
[TBL] [Abstract][Full Text] [Related]
2. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease.
Kaye JA; May C; Atack JR; Daly E; Sweeney DL; Beal MF; Kaufman S; Milstien S; Friedland RP; Rapoport SI
Ann Neurol; 1988 Nov; 24(5):647-50. PubMed ID: 2462403
[TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
Stuerenburg HJ; Ganzer S; Müller-Thomsen T
Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
[TBL] [Abstract][Full Text] [Related]
6. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
Eklundh T; Eriksson M; Sjöberg S; Nordin C
J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
[TBL] [Abstract][Full Text] [Related]
7. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis.
Markianos M; Koutsis G; Evangelopoulos ME; Mandellos D; Karahalios G; Sfagos C
J Neurochem; 2009 Jan; 108(1):158-64. PubMed ID: 19014375
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid catecholamine metabolites in HIV-infected patients.
Larsson M; Hagberg L; Forsman A; Norkrans G
J Neurosci Res; 1991 Mar; 28(3):406-9. PubMed ID: 1856886
[TBL] [Abstract][Full Text] [Related]
9. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
Jia JP; Jia JM; Zhou WD; Xu M; Chu CB; Yan X; Sun YX
Chin Med J (Engl); 2004 Aug; 117(8):1161-4. PubMed ID: 15361288
[TBL] [Abstract][Full Text] [Related]
10. Neurotransmitters in dementia.
Nakamura S; Koshimura K; Kato T; Yamao S; Iijima S; Nagata H; Miyata S; Fujiyoshi K; Okamoto K; Suga H
Clin Ther; 1984; 7 Spec No():18-34. PubMed ID: 6152197
[TBL] [Abstract][Full Text] [Related]
11. Amino acid concentration in dementia of the Alzheimer type and multi-infarct dementia.
Mochizuki Y; Oishi M; Hara M; Takasu T
Ann Clin Lab Sci; 1996; 26(3):275-8. PubMed ID: 8726221
[TBL] [Abstract][Full Text] [Related]
12. CSF neurotransmitter metabolites and neuropsychiatric symptomatology in patients with normal pressure hydrocephalus.
Markianos M; Lafazanos S; Koutsis G; Sfagos C; Seretis A
Clin Neurol Neurosurg; 2009 Apr; 111(3):231-4. PubMed ID: 19046799
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type.
Tune L; Gucker S; Folstein M; Oshida L; Coyle JT
Ann Neurol; 1985 Jan; 17(1):46-8. PubMed ID: 3985585
[TBL] [Abstract][Full Text] [Related]
14. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
[TBL] [Abstract][Full Text] [Related]
15. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
Davies P
Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427
[No Abstract] [Full Text] [Related]
16. [Effects of idebenone on monoamine metabolites in the cerebrospinal fluid of patients with cerebrovascular dementia].
Kawakami M; Itoh T
No To Shinkei; 1986 Feb; 38(2):187-93. PubMed ID: 2421750
[TBL] [Abstract][Full Text] [Related]
17. Biogenic amines in cerebrospinal fluid and plasma of patients with dementia of Alzheimer type.
Pinessi L; Rainero I; De Gennaro T; Gentile S; Portaleone P; Bergamasco B
Funct Neurol; 1987; 2(1):51-8. PubMed ID: 3678940
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid biopterin is decreased in Alzheimer's disease.
Kay AD; Milstien S; Kaufman S; Creasey H; Haxby JV; Cutler NR; Rapoport SI
Arch Neurol; 1986 Oct; 43(10):996-9. PubMed ID: 2428341
[TBL] [Abstract][Full Text] [Related]
19. Correlations between cisternal CSF and plasma concentrations of HVA, MHPG, 5-HIAA, DA, and NA.
Degrell I; Nagy E
Biol Psychiatry; 1990 May; 27(10):1179-82. PubMed ID: 1692743
[No Abstract] [Full Text] [Related]
20. Analysis of monoamines in the cerebrospinal fluid of Chinese patients with Alzheimer's disease.
Liu HC; Yang JC; Chang YF; Liu TY; Chi CW
Ann N Y Acad Sci; 1991; 640():215-8. PubMed ID: 1723257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
